559 related articles for article (PubMed ID: 18646463)
41. The potent adjuvant effects of chicken beta-defensin-1 when genetically fused with infectious bursal disease virus VP2 gene.
Zhang HH; Yang XM; Xie QM; Ma JY; Luo YN; Cao YC; Chen F; Bi YZ
Vet Immunol Immunopathol; 2010 Jul; 136(1-2):92-7. PubMed ID: 20334934
[TBL] [Abstract][Full Text] [Related]
42. DNA vaccination with VP2 gene fragment confers protection against Infectious Bursal Disease Virus in chickens.
Pradhan SN; Prince PR; Madhumathi J; Arunkumar C; Roy P; Narayanan RB; Antony U
Vet Microbiol; 2014 Jun; 171(1-2):13-22. PubMed ID: 24745626
[TBL] [Abstract][Full Text] [Related]
43. Effective protection by high efficiency bicistronic DNA vaccine against infectious bursal disease virus expressing VP2 protein and chicken IL-2.
Kumar S; Ahi YS; Salunkhe SS; Koul M; Tiwari AK; Gupta PK; Rai A
Vaccine; 2009 Feb; 27(6):864-9. PubMed ID: 19111591
[TBL] [Abstract][Full Text] [Related]
44. Recombinant Marek's disease virus type 1 provides full protection against very virulent Marek's and infectious bursal disease viruses in chickens.
Li K; Liu Y; Liu C; Gao L; Zhang Y; Cui H; Gao Y; Qi X; Zhong L; Wang X
Sci Rep; 2016 Dec; 6():39263. PubMed ID: 27982090
[TBL] [Abstract][Full Text] [Related]
45. Recombinant Semliki Forest virus vector exhibits potential for avian virus vaccine development.
Phenix KV; Wark K; Luke CJ; Skinner MA; Smyth JA; Mawhinney KA; Todd D
Vaccine; 2001 Apr; 19(23-24):3116-23. PubMed ID: 11312006
[TBL] [Abstract][Full Text] [Related]
46. Chimaeric VP2 proteins from infectious bursal disease virus containing the N-terminal M2e of H9 subtype avian influenza virus induce neutralizing antibody responses to both viruses.
Tang Y; Gong Y; Wang Y; Wu P; Liu Y; Lu J; Gao F; Chen T; Hou F; Hou J
Avian Pathol; 2013; 42(3):260-7. PubMed ID: 23607544
[TBL] [Abstract][Full Text] [Related]
47. Plasmid DNA encoding antigens of infectious bursal disease viruses induce protective immune responses in chickens: factors influencing efficacy.
Li J; Huang Y; Liang X; Lu M; Li L; Yu L; Deng R
Virus Res; 2003 Dec; 98(1):63-74. PubMed ID: 14609631
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of the immune response and detection of infectious bursal disease viruses by reverse transcriptase-polymerase chain reaction and enzyme-linked immunosorbent assay after in ovo vaccination of commercial broilers.
Corley MM; Giambrone JJ; Dormitorio TV
Avian Dis; 2002; 46(4):803-9. PubMed ID: 12495039
[TBL] [Abstract][Full Text] [Related]
49. Preparation and evaluation of Vero-cell infectious bursal disease vaccine in Pakistan.
Rasool MH; Hussain I
Vaccine; 2006 Apr; 24(15):2810-4. PubMed ID: 16490290
[TBL] [Abstract][Full Text] [Related]
50. Herpesvirus of turkey recombinant viruses expressing infectious bursal disease virus (IBDV) VP2 immunogen induce protection against an IBDV virulent challenge in chickens.
Darteil R; Bublot M; Laplace E; Bouquet JF; Audonnet JC; Rivière M
Virology; 1995 Aug; 211(2):481-90. PubMed ID: 7645252
[TBL] [Abstract][Full Text] [Related]
51. Development and large-scale use of recombinant VP2 vaccine for the prevention of infectious bursal disease of chickens.
Pitcovski J; Gutter B; Gallili G; Goldway M; Perelman B; Gross G; Krispel S; Barbakov M; Michael A
Vaccine; 2003 Dec; 21(32):4736-43. PubMed ID: 14585684
[TBL] [Abstract][Full Text] [Related]
52. Virus-like particles of hepatitis B virus core protein containing five mimotopes of infectious bursal disease virus (IBDV) protect chickens against IBDV.
Wang YS; Ouyang W; Liu XJ; He KW; Yu SQ; Zhang HB; Fan HJ; Lu CP
Vaccine; 2012 Mar; 30(12):2125-30. PubMed ID: 22285269
[TBL] [Abstract][Full Text] [Related]
53. Efficacy and safety of an infectious bursal disease virus intermediate vaccine in ovo.
Coletti M; Del Rossi E; Franciosini MP; Passamonti F; Tacconi G; Marini C
Avian Dis; 2001; 45(4):1036-43. PubMed ID: 11785875
[TBL] [Abstract][Full Text] [Related]
54. DNA immunization against very virulent infectious bursal disease virus with VP2-4-3 gene and chicken IL-6 gene.
Sun JH; Yan YX; Jiang J; Lu P
J Vet Med B Infect Dis Vet Public Health; 2005 Feb; 52(1):1-7. PubMed ID: 15702994
[TBL] [Abstract][Full Text] [Related]
55. Active cross-protection induced by a recombinant baculovirus expressing chimeric infectious bursal disease virus structural proteins.
Snyder DB; Vakharia VN; Mengel-Whereat SA; Edwards GH; Savage PK; Lütticken D; Goodwin MA
Avian Dis; 1994; 38(4):701-7. PubMed ID: 7702501
[TBL] [Abstract][Full Text] [Related]
56. Active and passive protection against variant and classic infectious bursal disease virus strains induced by baculovirus-expressed structural proteins.
Vakharia VN; Snyder DB; Lütticken D; Mengel-Whereat SA; Savage PK; Edwards GH; Goodwin MA
Vaccine; 1994 Apr; 12(5):452-6. PubMed ID: 8023554
[TBL] [Abstract][Full Text] [Related]
57. The effect of co-administration of DNA carrying chicken interferon-gamma gene on protection of chickens against infectious bursal disease by DNA-mediated vaccination.
Hsieh MK; Wu CC; Lin TL
Vaccine; 2006 Nov; 24(47-48):6955-65. PubMed ID: 17050043
[TBL] [Abstract][Full Text] [Related]
58. Novel in-ovo chimeric recombinant Newcastle disease vaccine protects against both Newcastle disease and infectious bursal disease.
Ge J; Wang X; Tian M; Wen Z; Feng Q; Qi X; Gao H; Wang X; Bu Z
Vaccine; 2014 Mar; 32(13):1514-21. PubMed ID: 24486349
[TBL] [Abstract][Full Text] [Related]
59. Comparison of homologous and heterologous prime-boost immunizations combining MVA-vectored and plant-derived VP2 as a strategy against IBDV.
Richetta M; Gómez E; Lucero MS; Chimeno Zoth S; Gravisaco MJ; Calamante G; Berinstein A
Vaccine; 2017 Jan; 35(1):142-148. PubMed ID: 27876199
[TBL] [Abstract][Full Text] [Related]
60. Field efficacy trial of a novel HVT-IBD vector vaccine for 1-day-old broilers.
Le Gros FX; Dancer A; Giacomini C; Pizzoni L; Bublot M; Graziani M; Prandini F
Vaccine; 2009 Jan; 27(4):592-6. PubMed ID: 19041678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
